Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on May 22, 2026 by admin

Multimodal Pharmacological Study of Clinical Cohorts for Major Depressive Disorder

Conditions: Major Depressive Disorder (MDD

Interventions: Drug: Therapeutic intervention

Sponsors: Shanghai Mental Health Center; Lingang National Laboratory

Not yet recruiting
CategoriesClinicalTrials.gov TagsAcademic research, Depression, Medication, Mental health, News Approved

Post navigation

Previous PostPrevious Validation of the CIDI 5.0 Against the SCID-5 for Lifetime Mental Disorders
Next PostNext Eating Disorder Dynamic Intervention
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.